Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Lilly diabetes drug slashes deaths in patients with heart risk

Friday, September 18, 2015

Eli Lilly and Cos new Jardiance pill slashed deaths by percent in patients with type diabetes at risk of heart attack and stroke a finding that could make it a mainstay diabetes treatment and triple its use according to researchers and analysts Li...

Cannabis drug shows promise in treating schizophrenia

Wednesday, September 16, 2015

An experimental cannabis drug for treating schizophrenia developed by UKbased GW Pharmaceuticals Plc was found to be superior to a placebo in a midstage trial The companys UKlisted shares jumped percent while USlisted shares were up pct The drug...

Amgen to buy Dezima Pharma for $300 mln in cash

Wednesday, September 16, 2015

Amgen Inc said it will buy biotechnology company Dezima Pharma BV adding another cholesterol drug to its expanding portfolio of treatments for cardiovascular diseases Amgen said it will pay million in cash for the Netherlandsbased company and up to...

Acacia Pharma hopes to raise up to $230 mln in London IPO

Tuesday, September 15, 2015

Acacia Pharma a specialist in finding new uses for existing medicines or repurposing them said on Monday it planned to float in London marking a further boost for British pharmaceutical and biotech fundraising One person familiar with the plan said...

Kite Pharma expands collaboration with Netherlands Cancer Institute (NKI)

Tuesday, September 15, 2015

Kite Pharma Inc announced that it has expanded its collaboration with the Netherlands Cancer Institute NKI Kite and the NKI have entered into an agreement under which Kite will receive from the NKI the exclusive option to license multiple T cell rece...

Txcell granted US orphan drug designation for Col-Treg

Monday, September 14, 2015

Txcell granted US orphan drug designation for ColTreg in the treatment of chronic noninfectious uveitis Txcell plans to move ColTreg into a first clinical study in with top line results expected end reuterscom

Sanofi's combination diabetes drug hits goal in second late-stage trial

Monday, September 14, 2015

Sanofi said on Monday a second latestage Phase III study of its LixiLan diabetes drug had met its main target readying it for regulatory submissions by the fourth quarter in the United States and the first quarter of next year in the European Union...

Amgen seeks FDA approval for monthly dosing option for Repatha

Saturday, September 12, 2015

Amgen Inc said on Friday it had asked the US Food and Drug Administration to approve a monthly singledosing option for its recently approved cholesterol drug Repatha The FDA approved Repatha one of two expensive treatments in a new class of injecta...

Isis Pharmaceuticals expands partnership with AstraZeneca

Saturday, September 12, 2015

Isis Pharmaceuticals Inc received regulatory clearance Friday for its partnership with AstraZeneca by which the companies will develop antisense drugs for cardiovascular metabolic and renal diseases Carlsbad Califbased Isis will receive a million u...

Suven Life gets patents for neurodegenerative drug

Friday, September 11, 2015

Biopharma firm Suven Life Sciences today said it has been granted one patent each in nations including China and Israel for a drug used in the treatment of neurodegenerative diseases Neurodegenerative diseases include Alzheimers Schizophrenia and P...